Osteoarthritis cartilage targeting gadolinium-based magnetic resonance imaging contrast agent and preparation method thereof
A magnetic resonance imaging and osteoarthritis technology, which is applied in the direction of medical formula, preparations for in vivo tests, emulsion delivery, etc., to avoid systemic toxic and side effects, improve the effect of diagnosis and treatment, and improve biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0041] In another typical embodiment of the present invention, a method for preparing the aforementioned cartilage-targeted gadolinium-based magnetic resonance imaging contrast agent for osteoarthritis is provided, the preparation method comprising the following steps:
[0042] (1) Gd 2 CO 3 Nanoparticles were dispersed in Tris-HCl buffer solution, dropped into dopamine solution, stirred, and then centrifuged to obtain Gd coated with dopamine shell on the surface 2 CO 3 Nanoparticles, i.e. Gd 2 CO 3 @PDA nanoparticles;
[0043] (2) with step (1) gained Gd 2 CO 3 @PDA nanoparticles dispersed in deionized water, adding NH 2 -mPEG-SH, stirred, and then centrifuged to obtain Gd modified with polyethylene glycol on the surface of the dopamine shell 2 CO 3 Nanoparticles, i.e. Gd 2 CO 3 @PDA-PEG nanoparticles;
[0044] (3) The cartilage-targeting polypeptide whose amino acid sequence is DWRVIIPPRPSA is connected to the Gd obtained in step (2) through an amide condensation...
Embodiment 1
[0051] A method for preparing a cartilage-targeted gadolinium-based magnetic resonance imaging contrast agent for osteoarthritis according to an embodiment of the present invention, comprising the following steps:
[0052] (1) Synthesis of Gd 2 CO 3 nanoparticles
[0053] 0.5mM GdCl 3 .6H 2 O and 2.7g of urea were dissolved in 35mL of deionized water, stirred and reacted at 80°C; during the reaction, the color of the system changed from colorless to milk-like color; min, separated to get Gd 2 CO 3 nanoparticles;
[0054] (2) Synthesis of Gd 2 CO 3 @PDA nanoparticles
[0055] The 2mg / mL Gd obtained by synthesis of the above step (1) 2 CO 3 Nanoparticles were dispersed in 30mL of 10mM Tris-HCl (pH=8.5), and 5mL of dopamine solution (2mg / mL) was dripped clockwise, and the system was stirred overnight to obtain a black solution; Gd was separated by high-speed centrifugation (10000rpm) for 10 minutes. 2 CO 3 @PDA nanoparticles;
[0056] (3) Synthesis of Gd 2 CO 3 @P...
Embodiment 2
[0074] A method for preparing a cartilage-targeted gadolinium-based magnetic resonance imaging contrast agent for osteoarthritis according to an embodiment of the present invention, comprising the following steps:
[0075] (1) Synthesis of Gd 2 CO 3 nanoparticles
[0076] 0.5mM GdCl 3 .6H 2 O and 2.7g of urea were dissolved in 35mL of deionized water, stirred and reacted at 80°C; during the reaction, the color of the system changed from colorless to milk-like color; after 2 hours of reaction, the milk-like nanoparticles were centrifuged at a high speed (12000rpm) for 10 min, separated to get Gd 2 CO 3 nanoparticles;
[0077] (2) Synthesis of Gd 2 CO 3 @PDA nanoparticles
[0078] The 2mg / mL Gd obtained by synthesis of the above step (1) 2 CO 3 Nanoparticles were dispersed in 30mL of 10mM Tris-HCl (pH=8.5), and 5mL of dopamine solution (2mg / mL) was dripped clockwise, and the system was stirred overnight to obtain a black solution; Gd was separated by high-speed centri...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com